Seeking Alpha - Healthcare Revolution Medicines and EQRx stockholders approve acquisition...\n more…
Globe Newswire Transaction on Track to Close in November 2023REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology...\n more…
Simply Wall St Key Insights Given the large stake in the stock by institutions, EQRx's stock price might be vulnerable to their...\n more…